Compare DexCom, Inc. (DXCM) vs Clear Secure Inc (YOU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Clear Secure Inc — how do they compare? DexCom, Inc. trades at $78.49 (market cap $28.06B), while Clear Secure Inc trades at $54.94 (market cap $5.51B). The key difference: DexCom, Inc. is far larger — about 5.1× Clear Secure Inc's market cap, and Clear Secure Inc pays a 1.1% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | YOU | |
|---|---|---|
Market Cap | $28.06B | $5.51B |
Sector | Health | Technology |
52-Week High | $89.53 | $62.36 |
52-Week Low | $54.84 | $28.84 |
Enterprise Value | $27.03B | $4.82B |
Dividend Yield | — | 1.1% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $74.12, down 2.92% on the day, with a bullish technical signal from moving averages. The company demonstrates strong fundamentals with consistent revenue growth, expanding profit margins, and a track record of beating earnings estimates. Recent regulatory approvals for its G7 15-day CGM in Canada and pediatric clearance for its Stelo OTC system in the U.S. highlight ongoing product expansion.
The investment thesis centers on DexCom's leadership in the growing CGM market, supported by strong financial execution and analyst optimism. Key risks include competition from Abbott, the commercial unproven nature of expansion into non-insulin Type 2 diabetes patients, and potential disruption from GLP-1 drug adoption. The consensus price target of $84.33 suggests ~14% upside from current levels.
Clear Secure (YOU) trades at $54.77, up 2.3% with neutral technical signals. The company demonstrates strong profitability with 65.48% gross margins and 81.15% ROE, though valuation metrics appear elevated with a P/E of 43.72. Recent Q1 2026 earnings beat expectations at $0.38 EPS versus $0.35 expected. Analyst sentiment is balanced with 44% buy ratings and a $56.67 consensus target. Recent developments include AWS integration and airport expansion driving growth prospects.
The stock presents growth potential with expanding revenue and strategic partnerships, but faces valuation concerns and competitive pressures. Upside catalysts include continued travel recovery and new contract wins, while risks involve execution challenges and market volatility. The balanced analyst coverage suggests moderate near-term appreciation potential to the $56-57 range.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Clear Secure Inc
Clear Secure operates a secure identity platform that uses biometrics—specifically eyes, face, and fingerprints—to automate and expedite identity verification. While its most visible application is the CLEAR Plus airport subscription service, the company functions as a broad-based identity layer for travel, healthcare, and digital services, aiming to replace physical IDs with a secure, biometric link.
Read more on YOU →
